• PhRMA Negotiation Lawsuit Dismissed in TX Court

  Published On: 02/13/2024

• Pill Penalty Fix Bill (9-to-13) Unlikely to Pass

  Published On: 02/06/2024

• CMS Price Offers Going Out As R&D Expensing Bipartisan Vote Takes Place Tonight

  Published On: 01/31/2024

• MA Rates: -0.16% Without Risk Score Growth

  Published On: 01/31/2024

• Cell & Gene Therapy CMS Model Prioritizes Sickle Cell

  Published On: 01/30/2024

• House & Senate Bills Seek to Wall Off Chinese Firms

  Published On: 01/26/2024

• MA: Transparency Sought by CMS

  Published On: 01/26/2024

• Trump Wins New Hampshire Primary

  Published On: 01/23/2024

• MA & Part D Outlook 2025

  Published On: 01/22/2024

• Medicare Advantage (MA) Monthly Enrollment

  Published On: 01/18/2024

• FDA & CMS Double Down on Lab Developed Tests

  Published On: 01/18/2024

• Trump Wins Handily in Iowa

  Published On: 01/15/2024

• MedPAC: MA Overpaid at 123% FFS

  Published On: 01/12/2024

• JPM 2024: Health Policy Takeaways

  Published On: 01/11/2024

• Record ‘24 Enrollment (20 M) in Exchange

  Published On: 01/10/2024

• 48 Meds Targeted for Inflationary Rebate Penalties

  Published On: 12/14/2023

• +5.6% Hospital Update for 2025 (MedPAC)

  Published On: 12/08/2023

• March-in Rights Guidance Released

  Published On: 12/07/2023

• Anti-PBM Bills Pass Key Committee (Not Dead)

  Published On: 12/06/2023

• Multi Cancer Tests: Not One Size Fits All

  Published On: 12/05/2023

Previous181920Next